Danaher Corporation (DHR)
NYSE: DHR · Real-Time Price · USD
194.44
-1.31 (-0.67%)
At close: Jun 18, 2025, 4:00 PM
194.40
-0.04 (-0.02%)
After-hours: Jun 18, 2025, 7:00 PM EDT
Danaher Revenue
Danaher had revenue of $5.74B in the quarter ending March 28, 2025, a decrease of -0.95%. This brings the company's revenue in the last twelve months to $23.82B, up 0.35% year-over-year. In the year 2024, Danaher had annual revenue of $23.88B, down -0.06%.
Revenue (ttm)
$23.82B
Revenue Growth
+0.35%
P/S Ratio
5.92
Revenue / Employee
$378,095
Employees
63,000
Market Cap
139.15B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 23.88B | -15.00M | -0.06% |
Dec 31, 2023 | 23.89B | -2.75B | -10.33% |
Dec 31, 2022 | 26.64B | 1.84B | 7.42% |
Dec 31, 2021 | 24.80B | 2.52B | 11.30% |
Dec 31, 2020 | 22.28B | 4.37B | 24.42% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
DHR News
- 8 hours ago - Danaher: High Capex And Low Debt Despite Trump Legislation - Seeking Alpha
- 2 days ago - Danaher Schedules Second Quarter 2025 Earnings Conference Call - PRNewsWire
- 15 days ago - Prosperity Partners Completes Acquisition of Danaher Attig & Plante - Business Wire
- 17 days ago - SCIEX Sets a New Standard in Accurate Mass Quantitation With the ZenoTOF 8600 System and New Software Collaborations - Business Wire
- 17 days ago - Software Launches for SCIEX OS Ecosystem to Help Scientists Accelerate Discoveries and Streamline Lab Operations - Business Wire
- 17 days ago - SCIEX and Evosep expand access to standardized proteomics for Pharma and Biotech with new reseller agreement - Business Wire
- 21 days ago - Danaher Announces Diagnostic Development and Commercialization Partnership to Scale Precision Medicine - PRNewsWire
- 5 weeks ago - Danaher Corporation (DHR) BofA Securities 2025 Healthcare Conference (Transcript) - Seeking Alpha